Td Waterhouse Canada Inc. Cybin Inc. Transaction History

Td Waterhouse Canada Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$0.19 - $10.34 $19,948 - $1.09 Million	-104,991 Closed	0 $0
Q2 2024 Nov 12, 2024	SELL	$0.26 - $0.46 $1,302 - $2,303	-5,008 Reduced 4.55%	104,991 $28.2 Million
Q1 2024 May 10, 2024	BUY	$0.3 - $0.46 $19,999 - $30,666	66,666 Added 153.85%	109,999 $60.5 Million
Q2 2023 Nov 13, 2023	BUY	$0.23 - $0.39 $1,226 - $2,079	5,333 Added 14.03%	43,333 $25.1 Million
Q1 2023 Nov 13, 2023	BUY	$0.3 - $0.56 $10,650 - $19,880	35,500 Added 1420.0%	38,000 $18.7 Million
Q3 2022 Nov 13, 2023	BUY	$0.48 - $1.11 $1,200 - $2,775	2,500 New	2,500 $1.44 Million
Q2 2022 Nov 13, 2023	SELL	$0.41 - $0.88 $697 - $1,496	-1,700 Closed	0 $0
Q1 2022 Nov 13, 2023	BUY	$0.74 - $1.22 $710 - $1,171	960 Added 129.73%	1,700 $1.84 Million
Q4 2021 Nov 13, 2023	BUY	$1.13 - $2.31 $836 - $1,709	740 New	740 $1.11 Million

66.1K

Ticker CYBN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 166,120,000
Market Cap $1.65B
Description
Cybin Inc., a biopharmaceutical company, focuses on developing psychedelic-based therapeutics. The company's development pipeline includes CYB003, a deuterated psilocybin analog to treat major depressive and alcohol use disorders; CYB004, a deuterated dimethyltryptamine for treating anxiety disorders; and CYB005, a phenethylamine derivative to t...

Get notified when there are updates to the investment portfolio of Td Waterhouse Canada Inc., based on Form 13F filings with the SEC.

Stay updated on Td Waterhouse Canada Inc. with notifications on news.